GSC-1

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameGSC-1
Drug Alias Namealpha-glucosidase inhibitor (Dharma Biomedical)GSC-1
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionMaltase-glucoamylase inhibitors
TargetsMaltase-glucoamylase
Therapy Area/IndicationsHyperglycemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDharma Biomedical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDharma Biomedical
Active IndicationsN/A
Inactive IndicationsHyperglycemia

Other Information

ATC CodeN/A
Related LinksN/A